372 related articles for article (PubMed ID: 30509171)
1. The possible molecular mechanisms of farnesol on the antifungal resistance of C. albicans biofilms: the regulation of CYR1 and PDE2.
Chen S; Xia J; Li C; Zuo L; Wei X
BMC Microbiol; 2018 Dec; 18(1):203. PubMed ID: 30509171
[TBL] [Abstract][Full Text] [Related]
2. In vitro inhibitory effects of farnesol and interactions between farnesol and antifungals against biofilms of Candida albicans resistant strains.
Xia J; Qian F; Xu W; Zhang Z; Wei X
Biofouling; 2017 Apr; 33(4):283-293. PubMed ID: 28317391
[TBL] [Abstract][Full Text] [Related]
3. Farnesol and dodecanol effects on the Candida albicans Ras1-cAMP signalling pathway and the regulation of morphogenesis.
Davis-Hanna A; Piispanen AE; Stateva LI; Hogan DA
Mol Microbiol; 2008 Jan; 67(1):47-62. PubMed ID: 18078440
[TBL] [Abstract][Full Text] [Related]
4. Possible inhibitory molecular mechanism of farnesol on the development of fluconazole resistance in Candida albicans biofilm.
Yu LH; Wei X; Ma M; Chen XJ; Xu SB
Antimicrob Agents Chemother; 2012 Feb; 56(2):770-5. PubMed ID: 22106223
[TBL] [Abstract][Full Text] [Related]
5. Effect of filamentation and mode of growth on antifungal susceptibility of Candida albicans.
Watamoto T; Samaranayake LP; Jayatilake JA; Egusa H; Yatani H; Seneviratne CJ
Int J Antimicrob Agents; 2009 Oct; 34(4):333-9. PubMed ID: 19376687
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional regulation of drug-resistance genes in Candida albicans biofilms in response to antifungals.
Watamoto T; Samaranayake LP; Egusa H; Yatani H; Seneviratne CJ
J Med Microbiol; 2011 Sep; 60(Pt 9):1241-1247. PubMed ID: 21474609
[TBL] [Abstract][Full Text] [Related]
7. A possible mechanism of farnesol tolerance in
Chen S; Xu Z; Liu S; Duan W; Huang Y; Wei X
J Med Microbiol; 2022 Jan; 71(1):. PubMed ID: 35020583
[No Abstract] [Full Text] [Related]
8. Farnesol and cyclic AMP signaling effects on the hypha-to-yeast transition in Candida albicans.
Lindsay AK; Deveau A; Piispanen AE; Hogan DA
Eukaryot Cell; 2012 Oct; 11(10):1219-25. PubMed ID: 22886999
[TBL] [Abstract][Full Text] [Related]
9. Human serum potentiates the expression of genes associated with antifungal drug resistance in C. albicans biofilms on central venous catheters.
Samaranayake LP; Anil S; Hashem M; Vellappally S; Cheung BP
Mycopathologia; 2015 Apr; 179(3-4):195-204. PubMed ID: 25515243
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a hyperactive Cyr1 mutant reveals new regulatory mechanisms for cellular cAMP levels in Candida albicans.
Bai C; Xu XL; Wang HS; Wang YM; Chan FY; Wang Y
Mol Microbiol; 2011 Nov; 82(4):879-93. PubMed ID: 21992526
[TBL] [Abstract][Full Text] [Related]
11. Interaction of Candida albicans biofilms with antifungals: transcriptional response and binding of antifungals to beta-glucans.
Vediyappan G; Rossignol T; d'Enfert C
Antimicrob Agents Chemother; 2010 May; 54(5):2096-111. PubMed ID: 20194705
[TBL] [Abstract][Full Text] [Related]
12. In vitro interactions between farnesol and fluconazole, amphotericin B or micafungin against Candida albicans biofilms.
Katragkou A; McCarthy M; Alexander EL; Antachopoulos C; Meletiadis J; Jabra-Rizk MA; Petraitis V; Roilides E; Walsh TJ
J Antimicrob Chemother; 2015 Feb; 70(2):470-8. PubMed ID: 25288679
[TBL] [Abstract][Full Text] [Related]
13. cDNA microarray analysis of differential gene expression in Candida albicans biofilm exposed to farnesol.
Cao YY; Cao YB; Xu Z; Ying K; Li Y; Xie Y; Zhu ZY; Chen WS; Jiang YY
Antimicrob Agents Chemother; 2005 Feb; 49(2):584-9. PubMed ID: 15673737
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory Effect of Sophorolipid on Candida albicans Biofilm Formation and Hyphal Growth.
Haque F; Alfatah M; Ganesan K; Bhattacharyya MS
Sci Rep; 2016 Mar; 6():23575. PubMed ID: 27030404
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Biofilm Formation by
Lee JH; Kim YG; Khadke SK; Yamano A; Watanabe A; Lee J
ACS Infect Dis; 2019 Jul; 5(7):1177-1187. PubMed ID: 31055910
[No Abstract] [Full Text] [Related]
16. Tricyclic antidepressants inhibit Candida albicans growth and biofilm formation.
Caldara M; Marmiroli N
Int J Antimicrob Agents; 2018 Oct; 52(4):500-505. PubMed ID: 29990546
[TBL] [Abstract][Full Text] [Related]
17. Zap1 control of cell-cell signaling in Candida albicans biofilms.
Ganguly S; Bishop AC; Xu W; Ghosh S; Nickerson KW; Lanni F; Patton-Vogt J; Mitchell AP
Eukaryot Cell; 2011 Nov; 10(11):1448-54. PubMed ID: 21890817
[TBL] [Abstract][Full Text] [Related]
18. The inhibitory activity of linalool against the filamentous growth and biofilm formation in Candida albicans.
Hsu CC; Lai WL; Chuang KC; Lee MH; Tsai YC
Med Mycol; 2013 Jul; 51(5):473-82. PubMed ID: 23210679
[TBL] [Abstract][Full Text] [Related]
19. Activity of Sanguinarine against Candida albicans Biofilms.
Zhong H; Hu DD; Hu GH; Su J; Bi S; Zhang ZE; Wang Z; Zhang RL; Xu Z; Jiang YY; Wang Y
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223387
[No Abstract] [Full Text] [Related]
20. Bisbibenzyls, a new type of antifungal agent, inhibit morphogenesis switch and biofilm formation through upregulation of DPP3 in Candida albicans.
Zhang L; Chang W; Sun B; Groh M; Speicher A; Lou H
PLoS One; 2011; 6(12):e28953. PubMed ID: 22174935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
